本周末《纽约时报》的一系列大幅标题透露了参议院一个关于文迪雅的报告,其中包括了FDA某些人员常提出的指责和担心。比如一两年前在文迪雅顾问委员会上发表意见的Graham博士,他的意见大部分是基于Nissen和Wolski的荟萃分析,而这项事后分析的数据源于文迪雅的短期研究,这些研究主要是为了取得血糖控制的数据。之后发表的多 A series of big headlines this weekend in The New York Times revealed a Senate report on Avandia that included accusations and fears often raised by certain members of the FDA. For example, Dr. Graham, who expressed his opinion at the Avandia Advisory Board a year or two ago, most of his comments were based on a meta-analysis by Nissen and Wolski, and the data for this post-hoc analysis stems from Avandia’s short-term studies, Mainly in order to obtain blood glucose control data. After published more